Cellect Biotechnology to Present at the 2020 Cell & Gene Meeting on the Mesa
Management to Highlight Progress in Bone Marrow Transplant (BMT) and Chimeric Antigen Receptor T Cell (CAR T) Business CollaborationsTel Aviv, […]
Greenlane Holdings Appoints Key Sales and Marketing Hires for North America and Europe
Michael Cellucci, former President of Drew Estate Cigars, joins as President of Sales and Marketing of North AmericaMichael Ouwendij hired […]
Exagen Launches Test to Aid in the Detection of ANCA-Associated Vasculitis (AAV)
SAN DIEGO, Sept. 21, 2020 (GLOBE NEWSWIRE) — Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients […]
BolaWrap® Safely Restrains Suicidal Subject in Florida: Police Bodycam Footage Released
TEMPE, Ariz., Sept. 21, 2020 (GLOBE NEWSWIRE) — Wrap Technologies, Inc. (the “Company” or “Wrap”) (Nasdaq: WRTC) reported a successful […]
XBiotech Developing True Human Antibody Combination as Candidate Treatment for Influenza-COVID-19 Co-Infections
AUSTIN, Texas, Sept. 21, 2020 (GLOBE NEWSWIRE) — XBiotech Inc. (NASDAQ: XBIT) announced today it is developing a new breakthrough […]
TRACON Pharmaceuticals Highlights Updated Envafolimab Clinical Results in MSI-H/dMMR Colorectal Cancer
SAN DIEGO, Sept. 21, 2020 (GLOBE NEWSWIRE) — TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development […]
MEDIA ALERT: Industry-First, Global Influencer Marketing Alliance Announcement
Orlando, Florida, Sept. 21, 2020 (GLOBE NEWSWIRE) — IZEA Worldwide, Inc. (NASDAQ: IZEA), the premier provider of influencer marketing technology, […]
ARCA biopharma Announces Submission of IND Application to U.S. FDA for AB201 as a Potential Treatment for COVID-19
WESTMINSTER, Colo., Sept. 21, 2020 (GLOBE NEWSWIRE) — ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company applying a precision medicine […]
Daré Bioscience Receives $0.9 million Under the Current Grant Supplement Award for Continued Development of its User-Controlled, Long Acting Reversible Contraceptive (DARE-LARC1)
SAN DIEGO, Sept. 21, 2020 (GLOBE NEWSWIRE) — Daré Bioscience, Inc. (NASDAQ:DARE), a leader in women’s health innovation, today announced […]
Retrophin Announces Enrollment of First 280 Patients in Pivotal Phase 3 PROTECT Study of Sparsentan in IgA Nephropathy
SAN DIEGO, Sept. 21, 2020 (GLOBE NEWSWIRE) — Retrophin, Inc. (NASDAQ: RTRX) today announced that the first 280 patients have […]
